A Pilot Study of Topical Antiflammin-2 for Psoriasis
NCT00001371 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24
Last updated 2008-03-04
Summary
This study is a pilot trial designed to evaluate topical antiflammin-2, a phospholipase A2 (PLA2) inhibitor, in the treatment of chronic plaque psoriasis. Antiflammin-2 in an ointment base, or the vehicle alone will each be applied four times per day to a single plaque in a randomized, double-blinded fashion.
Conditions
Sponsors & Collaborators
-
National Cancer Institute (NCI)
lead NIH
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1993-12-31
- Completion
- 2000-12-31
Countries
- United States
Study Locations
More Related Trials
-
Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
NCT01938599 ·Status: COMPLETED ·Phase: PHASE2
-
Study Of The Mechanism Of Action Of CP-690,550 In The Skin Of Subjects With Moderate To Severe Chronic Plaque Psoriasis
NCT01710046 ·Status: COMPLETED ·Phase: PHASE2
-
Topical CP-690,550 For Chronic Plaque Psoriasis
NCT00678561 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of CF101 to Treat Psoriasis
NCT00428974 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Plaque Psoriasis
NCT02618616 ·Status: COMPLETED ·Phase: PHASE2
-
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
NCT02564042 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis
NCT02515097 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis
NCT03895372 ·Status: COMPLETED ·Phase: PHASE2
-
AN2728 Topical Ointment to Treat Mild-to-Moderate Plaque-Type Psoriasis
NCT01300052 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of BFH772 in Psoriasis Patients
NCT00987870 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis
NCT03381625 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis
NCT02445807 ·Status: COMPLETED ·Phase: PHASE3
-
CT 327 in the Treatment of Psoriasis Vulgaris
NCT00995969 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy
NCT06643260 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A First in Human Study to Evaluate Safety, Tolerability, and Pharmacology of PF-06826647 in Healthy Subjects and Subjects With Plaque Psoriasis
NCT03210961 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis
NCT00759161 ·Status: COMPLETED ·Phase: PHASE2
-
A Multicenter Study of 074-6751 Lotion in Subjects With Moderate Plaque Psoriasis
NCT03167515 ·Status: COMPLETED ·Phase: NA
-
A Study of PRCL-02 in Moderate to Severe Chronic Plaque Psoriasis
NCT03614078 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of a Novel Ointment to Treat Plaque Type Psoriasis
NCT01029405 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of PRCL-02 in Healthy Volunteers and Plaque Psoriasis
NCT03062618 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Evaluating the Effects of GLPG3667 Given as an Oral Treatment for 4 Weeks in Adults With Moderate to Severe Plaque Psoriasis
NCT04594928 ·Status: COMPLETED ·Phase: PHASE1
-
Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasis
NCT04664153 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis
NCT02514577 ·Status: COMPLETED ·Phase: PHASE3
-
Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques
NCT05642182 ·Status: RECRUITING ·Phase: PHASE1
-
Pivotal Efficacy and Safety Registration Trial of FP187 in Moderate to Severe Plaque Psoriasis
NCT01230138 ·Status: COMPLETED ·Phase: PHASE2